SGLT2 抑制剂伊普拉格利弗洛辛对调节皮肤功能的基因表达的影响
Nobutomo Ikarashi1, Keito Tabata1, Yui Shinozaki1
1Department of Biomolecular Pharmacology, Hoshi University, Tokyo, Japan.
Diabetic medicine : a journal of the British Diabetic Association
|December 22, 2024
概括
像伊普拉格利弗洛辛这样的依赖的葡萄糖携带体2型 (SGLT2) 抑制剂可能通过减少皮肤屏障和保湿功能的基因而导致皮肤疾病. 这项研究探讨了这些副作用的潜在预防措施.
科学领域:
- 药理学 药理学是指药理学的学科.
- 皮肤病学 皮肤病学
- 分子生物学分子生物学
背景情况:
- 皮肤疾病是依赖的葡萄糖共运输体2型 (SGLT2) 抑制剂的一种已知的副作用.
- 了解这些皮肤问题背后的分子机制对于制定预防策略至关重要.
研究的目的:
- 调查SGLT2抑制剂伊普拉格利弗洛辛对皮肤基因表达的影响.
- 确定潜在的分子标,以预防SGLT2抑制剂诱导的皮肤疾病.
主要方法:
- db/db2型糖尿病模型小鼠每天接受ipragliflozin (10 mg/kg或30 mg/kg) 治疗,持续28天.
- 与屏障和保湿功能相关的皮肤基因表达被使用实时RT-PCR和西式涂抹分析.
主要成果:
- 伊普拉格利弗洛辛治疗没有改变原蛋白的表达.
- 观察到参与氨酸和陶胺合成/分解的基因的表达显著下降.
- 在接受伊普拉格利弗洛辛治疗的小鼠中,费拉格林,洛里克林,弹性素和水素-3的表达减少.
结论:
- 伊普拉格利弗洛辛减少了负责皮肤屏障和水分的关键基因的表达.
- 这些分子变化可能是SGLT2抑制剂相关皮肤疾病的潜在机制.
相关概念视频
Dipeptidyl Peptidase 4 Inhibitors
178
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
178
Glucagon-like Receptor Agonists
305
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
305
Oral Hypoglycemic Agents: Biguanides and Glitazones
182
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
182
Oral Hypoglycemic Agents: Glinides
145
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
145
Cell Specific Gene Expression
13.5K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
13.5K
Glucose Transporters
22.5K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.5K


